Bridges Investment Management’s Novo Nordisk NVO Stock Holding History

Bridges Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$336K	Sell	7,011 -300	-4%	-$12.9K	﹤0.01%	351
2026 Q1	$269K	Hold	7,311	–	–	﹤0.01%	354
2025 Q4	$372K	Buy	7,311 +7	+0.1%	+$358	﹤0.01%	324
2025 Q3	$405K	Buy	7,304 +4	+0.1%	+$234	0.01%	317
2025 Q2	$504K	Sell	7,300 -250	-3%	-$17K	0.01%	289
2025 Q1	$524K	Buy	7,550 +250	+3%	+$20.6K	0.01%	281
2024 Q4	$628K	Sell	7,300 -400	-5%	-$43.3K	0.01%	261
2024 Q3	$917K	Buy	7,700 +150	+2%	+$20K	0.01%	208
2024 Q2	$1.08M	Buy	+7,550	New	+$1M	0.02%	182
2019 Q4	–	Sell	-45,938	Closed	-$1.19M	–	353
2019 Q3	$1.19M	Buy	45,938 +2,438	+6%	+$61.6K	0.05%	187
2019 Q2	$1.11M	Hold	43,500	–	–	0.04%	186
2019 Q1	$1.14M	Hold	43,500	–	–	0.05%	178
2018 Q4	$1M	Buy	43,500 +25,184	+137%	+$560K	0.05%	178
2018 Q3	$432K	Buy	+18,316	New	+$447K	0.02%	211

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bridges Investment Management's NVO Position: Q2 2026 in Review

Bridges Investment Management reduced its Novo Nordisk (NVO) stake by 4.1% in Q2 2026, selling an estimated $12.9K and leaving 7,011 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Bridges Investment Management first reported a position in NVO in Q3 2018 and has held it in 14 quarters since. The position peaked at $1.19M in Q3 2019. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Bridges Investment Management held 7,011 shares of Novo Nordisk worth $336K as of Q2 2026.
Bridges Investment Management sold 300 Novo Nordisk shares in Q2 2026, an estimated $12.9K.
Novo Nordisk made up ﹤0.01% of Bridges Investment Management's portfolio in Q2 2026, its #351 holding.
Bridges Investment Management first reported a position in Novo Nordisk in Q3 2018 and has held it in 14 quarters since.
Bridges Investment Management's Novo Nordisk position peaked at $1.19M in Q3 2019.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.